Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03033511
Title A Study of Rovalpituzumab Tesirine as Maintenance Therapy Following First-Line Platinum-Based Chemotherapy in Participants With Extensive Stage Small Cell Lung Cancer (MERU) (MERU)
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors AbbVie
Indications

lung small cell carcinoma

Therapies

Dexamethasone + Rovalpituzumab Tesirine

Age Groups: senior | adult
Covered Countries USA | CAN


No variant requirements are available.